CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2565
Detailed information
CancerLivER ID2565
Biomarker EphA2
Biomarker Name/Symbol (given in Publication)EphA2
BiomoleculeProtein and RNAs
SubjectHuman
Degree of ValidityPotential serum marker for the detection of HCC development and progression; but not validated on independent patients's cohort
Experimental ConditionHCC v/s non-tumor/normal; associated with the poor survival of patients
Cancer typeHepatocellular carcinoma
RegulationDownregulated in HCC
Level of significance p < 0.05
SourceTissue and Seum
PMID19642143
Type of BiomarkerDiagnostic and Prognostic
PathwayApoptosis
CohortHuman hepatoma cell lines, including HepG2 cells, Hep3B cells, PLC/PRF/5 cells, SK-Hep-1 cells and Chang liver cells were obtained from the American Type Culture Collection (Rockville, MD). Human hepatoma cell lines, including SH- J1 cells, HLK3 cells, HKK2 cells and HLK5 cells, were estab- lished f
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
DiseaseHCC v/s non-tumor/normal
Year of Publication2010
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top